Evidence map›Paper›PMID 36656900›Full record

ArticlePLoS neglected tropical diseases2023

Clinical and pathological characterization of Central Nervous System cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection.

Mohamed F Hamed, Vanessa Enriquez, Melissa E Munzen, Claudia L Charles-Niño, Mircea Radu Mihu, Habibeh Khoshbouei, Karina Alviña, Luis R Martinez

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. iScience · 2026
    Article
  5. Article
  6. Frontiers in immunology · 2025
    Article
  7. Host-membrane lipid composition controlsFrontiers in immunology · 2025
    Article
  8. Article
  9. Article
  10. mBio · 2024
    Article
  11. bioRxiv : the preprint server for biology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Mohamed F HamedDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, Florida, United States of America.
Vanessa EnriquezDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, Florida, United States of America.
Melissa E MunzenDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, Florida, United States of America.
Claudia L Charles-NiñoDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, Florida, United States of America.
Mircea Radu MihuAdvanced Critical Care, Nazih Zuhdi Transplant Institute, Advanced Cardiac Care and 24/7 Shock Service, Integris Baptist Medical Center, Oklahoma City, Oklahoma, United States of America.
Habibeh KhoshboueiDepartment of Neuroscience, University of Florida, Gainesville, Florida, United States of America.
Karina AlviñaDepartment of Neuroscience, University of Florida, Gainesville, Florida, United States of America.
Luis R MartinezDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, Florida, United States of America.ORCID 0000-0001-6372-6501
University of Florida · USINTEGRIS Baptist Medical Center · USMansoura University · EGUniversidad de Guadalajara · MX

Funding

Comprehensive Training Program in Oral BiologyT90DE021990 · NIDCR · UNIVERSITY OF FLORIDA · PI Jose A Lemos · 2011 to 2026
$8.2M
Alpha-synuclein Regulates Dopamine Transporter FunctionsR01NS071122 · NINDS · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2010 to 2022
$3.9M
Unraveling Cryptococcus neoformans mechanisms of brain invasion and colonizationR01AI145559 · NIAID · UNIVERSITY OF TEXAS EL PASO · PI MARTINEZ, LUIS R · 2019 to 2023
$2.6M
Comprehensive Training Program in Oral BiologyR90DE022530 · NIDCR · UNIVERSITY OF FLORIDA · PI LEMOS, JOSE A · 2011 to 2025
$995k
NIAID NIH HHS R01 AI145559NIDCR NIH HHS R90 DE022530NIDCR NIH HHS T90 DE021990NINDS NIH HHS R01 NS071122
6 · The paper itself

Abstract

Infection of the Central Nervous System (CNS) by the encapsulated fungus Cryptococcus neoformans can lead to high mortality meningitis, most commonly in immunocompromised patients. While the mechanisms by which the fungus crosses the blood-brain barrier to initiate infection in the CNS are well recognized, there are still substantial unanswered questions about the disease progression once the fungus is established in the brain. C. neoformans is characterized by a glucuronoxylomannan (GXM)-rich polysaccharide capsule which has been implicated in immune evasion, but its role during the host CNS infection needs further elucidation. Therefore, the present study aims to examine these key questions about the mechanisms underlying cryptococcal meningitis progression and the impact of fungal GXM release by using an intracerebral rodent infection model via stereotaxic surgery. After developing brain infection, we analyzed distinct brain regions and found that while fungal load and brain weight were comparable one-week post-infection, there were region-specific histopathological (with and without brain parenchyma involvement) and disease manifestations. Moreover, we also observed a region-specific correlation between GXM accumulation and glial cell recruitment. Furthermore, mortality was associated with the presence of subarachnoid hemorrhaging and GXM deposition in the meningeal blood vessels and meninges in all regions infected. Our results show that using the present infection model can facilitate clinical and neuropathological observations during the progression of neurocryptococcosis. Importantly, this mouse model can be used to further investigate disease progression as it develops in humans.

Indexed as

CryptococcosisCryptococcus neoformansMeningitis, CryptococcalAnimalsCentral Nervous SystemDisease Models, AnimalDisease ProgressionHumansMicePolysaccharidesPolysaccharides

Identifiers

PMID36656900
PMCPMC9888703
OpenAlexW4317437847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.